Thus, NSCLC tumors with genetic alterations in EGFR and ALK demonstrated a high prevalence of PD-L1 expression reflecting a predisposition to oncogene-driven immune escape. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.